JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 14 No. 6 321-325
© 1973 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ryo, U. Y.
Right arrow Articles by Beierwaltes, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ryo, U. Y.
Right arrow Articles by Beierwaltes, W. H.

Distribution of 14C-Isoxazole in Adrenals, Ovaries, and Breast Carcinoma

Ung Y. Ryo and William H. Beierwaltes

University of Michigan Medical Center, Ann Arbor, Michigan

Correspondence: For reprints contact: William H. Beierwaltes, Div. of Nuclear Medicine, Univ. of Michigan Medical Center, Ann Arbor, Mich. 48104.

ABSTRACT

Studies were performed in rats and patients with breast cancer to evaluate tissue binding of an enzyme inhibitor, isoxazole, which had been shown to accumulate in rat adrenals. The findings of persistent retention of the inhibitor in the rat adrenal were confirmed, but retention of the inhibitor in cancer tissue was not shown, although the specific enzymes had been present in breast cancer in one reported instance. An unexpected observation was the high concentration of the inhibitor in fat, possibly analogous to that of estrogens.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1973 by the Society of Nuclear Medicine.